On July 21, Zhuhai Techno Maibo Pharmaceutical Co., Ltd., the first phase investment enterprise of Gaolin Venture Capital, a sub-fund of the Shanghai Science and Technology Innovation Fund, was listed on the Science and Technology Innovation Board, and the number of IPOs in the Shanghai Science and Technology Innovation Fund's portfolio increased to 228. The target size of the Shanghai Science and Technology Innovation Fund is 30 billion yuan, and the current management scale exceeds 20 billion yuan. Up to now, the Shanghai Science and Technology Innovation Fund has invested in more than 100 sub-funds, with a total sub-fund contract size of nearly 300 billion yuan. There are more than 3,000 portfolio companies, including 228 listed companies and more than 780 national-level specialized and innovative “little giant” enterprises.

On July 21, Zhuhai Techno Maibo Pharmaceutical Co., Ltd., the first phase investment enterprise of Gaolin Venture Capital, a sub-fund of the Shanghai Science and Technology Innovation Fund, was listed on the Science and Technology Innovation Board, and the number of IPOs in the Shanghai Science and Technology Innovation Fund's portfolio increased to 228. The target size of the Shanghai Science and Technology Innovation Fund is 30 billion yuan, and the current management scale exceeds 20 billion yuan. Up to now, the Shanghai Science and Technology Innovation Fund has invested in more than 100 sub-funds, with a total sub-fund contract size of nearly 300 billion yuan. There are more than 3,000 portfolio companies, including 228 listed companies and more than 780 national-level specialized and innovative “little giant” enterprises.